Anti-Cathepsin B Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the propeptide domain of human Cathepsin B (CTSB), validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Mouse, Rat, Pan, Monkey, Dog, Pig
UniProt
P07858
Size
100ug
Cat. #
RP1CathepsinB

In stock

SKU
RP-CathepsinB

Options

As low as: $130.00

Target Overview

Cathepsin B (CTSB, EC 3.4.22.1, UniProt P07858) is a lysosomal cysteine protease belonging to the papain superfamily. As a thiol protease, Cathepsin B participates in intracellular protein degradation and turnover, cleaving substrates including matrix extracellular phosphoglycoprotein (MEPE) and contributing to the solubilization of cross-linked thyroglobulin in thyroid follicle lumens. The 339-amino acid enzyme is synthesized as a prepropeptide and undergoes proteolytic maturation to yield a two-chain active form. Cathepsin B exhibits both endopeptidase and exopeptidase activity, distinguishing it from other cathepsins. Its lysosomal localization places it at the center of autophagy, antigen processing, and ECM remodeling. Researchers study Cathepsin B in contexts ranging from thyroid physiology to cancer biology, where its role in tumor invasion and metastasis has been documented since the 1980s. The enzyme has also been identified as an APP secretase, implicating it in amyloid precursor protein processing relevant to neurodegenerative disease models.

Background

Cathepsin B functions primarily within the acidic environment of lysosomes, where it degrades intracellular proteins delivered via autophagy and endocytosis. Its dual catalytic capability—both endopeptidase and carboxypeptidase activity—enables cleavage of diverse substrates. Beyond housekeeping proteolysis, Cathepsin B participates in specialized processes including thyroid hormone liberation, bone resorption, and antigen presentation. The enzyme's involvement in pathological states has driven significant research interest. Tumor cells often overexpress and secrete Cathepsin B, facilitating extracellular matrix degradation and promoting invasion and metastasis. Recent work has expanded its functional scope: Jiang et al. (2026) demonstrated that suppression of Cathepsin B-mediated ferroptosis promotes pancreatic cancer progression, establishing a mechanistic link between CLEC4G expression and cathepsin-regulated cell death pathways. Zierke et al. (2026) identified upregulated Cathepsin B in ER-stress and ER-phagy responses during acute pancreatitis models lacking the CLN8 cargo protein, highlighting its role in cellular stress adaptation. Cathepsin B is also implicated in inflammatory and autophagy pathways. Wang et al. (2026) reported hypoxia-induced upregulation of Cathepsin B in dental pulpitis models, where it contributed to protective autophagy responses. In metabolic and neurodegenerative contexts, the enzyme's dysregulation correlates with disease progression, making it a target for diagnostic and therapeutic investigation. Ma et al. (2026) included CTSB among ferroptosis-related genes with diagnostic value in gastric cancer, reflecting growing interest in cathepsin-mediated cell death regulation. Triple Point Biologics offers two rabbit polyclonal antibodies targeting the propeptide domain of human Cathepsin B, validated for Western blot applications across human samples and predicted to cross-react with mouse, rat, primate, canine, and porcine orthologs.

References

  1. Wang X et al (2026) Hypoxia-induced inflammation and protective autophagy in dental pulpitis. Arch Oral Biol. PubMed · DOI
  2. Ma W et al (2026) Multi-algorithm machine learning combined with in silico gene knockout reveals the diagnostic value and functional regulatory networks of ferroptosis-related genes in gastric cancer. Transl Cancer Res. PubMed · DOI
  3. Zierke L et al (2026) Loss of the ER-cargo protein CLN8 increases severity of acute pancreatitis and upregulates ER-stress and ER-phagy. Mol Biomed. PubMed · DOI
  4. Mahmoudi A et al (2026) Exploring the Potential of Calebin-A in Targeting Obesity-Related Genes and Pathways. J Cell Mol Med. PubMed · DOI
  5. Jiang Z et al (2026) CLEC4G Promotes Pancreatic Cancer Progression by Suppressing Cathepsin B-Mediated Ferroptosis: Evidence From Mendelian Randomization Study and Experimental Validation. Hum Mutat. PubMed · DOI

Additional Specifications

Gene Symbol CTSB
UniProt ID P07858
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Mouse, Rat, Pan, Monkey, Dog, Pig
Pack Size 100ug
Immunogen (Propeptide domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 18-79.
Immunogen (Heavy chain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 129-333.
Alternate Names CTSB, Cathepsin B, Cathepsin B1, APP secretase, APPS, EC 3.4.22.1

Frequently Asked Questions

What molecular weight band should I expect for Cathepsin B on Western blot?

Cathepsin B is synthesized as a 339-amino acid prepropeptide (~37 kDa) that undergoes proteolytic maturation in the lysosome. On Western blots, you will typically observe the mature two-chain form as a predominant band at approximately 25-30 kDa, representing the heavy and light chains held together by disulfide bonds under non-reducing conditions. Under reducing conditions, you may see the individual chains around 25 kDa and 5 kDa, though the smaller chain often runs off standard gels. In some lysates, particularly those with active lysosomal processing, you may also detect the pro-form at 37-43 kDa depending on glycosylation state.

What starting dilution should I use for Cathepsin B Western blots?

We recommend starting at 1:1000 dilution for Western blot applications with this polyclonal antibody. Cathepsin B is relatively abundant in lysosome-rich tissues and most cultured cell lines, so 1:1000 typically provides strong signal without excessive background. If working with tissues where Cathepsin B is highly expressed—such as liver, kidney, or thyroid—you may achieve acceptable results at 1:2000 or even 1:5000. Conversely, if studying cells with low lysosomal content or following knockdown experiments, begin at 1:500 to ensure detection. Titrate against your specific sample type; overnight incubation at 4°C often improves sensitivity over one-hour room-temperature protocols.

Is this Cathepsin B antibody validated in mouse and rat samples?

This antibody is validated in human samples. Mouse and rat are listed as predicted cross-reactive species based on sequence homology in the immunogen region; human, mouse, and rat Cathepsin B share approximately 85-90% identity across the mature enzyme. We have not internally validated performance in rodent lysates, so if you are working with mouse or rat samples, we recommend confirming specificity with a positive control lysate known to express Cathepsin B and including a Cathepsin B-knockout or knockdown sample if available. Published literature shows substantial cross-reactivity for most polyclonal Cathepsin B antibodies across mammalian species, but titre optimization may be necessary.

What sample preparation preserves Cathepsin B signal best?

Cathepsin B is a lysosomal cysteine protease that remains active in mildly acidic conditions and can undergo autocatalytic processing if lysates are mishandled. Lyse cells or tissues in cold RIPA or similar buffer containing protease inhibitor cocktail; include E-64 or other cysteine protease inhibitors to prevent autodegradation and artifactual processing of the pro-form. Keep samples on ice and process quickly; freeze aliquots immediately if not running the same day. Avoid repeated freeze-thaw cycles, which promote aggregation and processing. For IHC applications, standard formalin fixation and paraffin embedding are compatible; antigen retrieval with citrate buffer (pH 6.0) at sub-boiling temperature typically yields optimal epitope exposure for this antibody.

Does Cathepsin B show both endopeptidase and exopeptidase activity, and does antibody binding interfere?

Cathepsin B is unusual among cathepsins in exhibiting both endopeptidase and carboxydipeptidase (exopeptidase) activity due to a unique occluding loop near its active site. This antibody is a polyclonal raised against a broad region of the protein and is intended for detection applications—Western blot—not for functional inhibition or activity assays. Antibody binding may sterically interfere with substrate access if used in co-immunoprecipitation followed by activity measurements, though this has not been systematically tested. For enzymatic assays, use the antibody for post-assay validation or localization studies rather than during the catalytic reaction itself.

What are good positive and negative controls for Cathepsin B experiments?

Positive controls should include lysates from lysosome-rich cell types such as HeLa, RAW264.7 macrophages, or primary hepatocytes, all of which express Cathepsin B constitutively. Thyroid tissue lysates are particularly strong positive controls given Cathepsin B's role in thyroglobulin processing. For negative controls, consider lysates from cells treated with Cathepsin B-targeting siRNA or CRISPR knockout lines if available; these confirm antibody specificity. Alternatively, preincubate the antibody with recombinant Cathepsin B protein as a blocking peptide competition assay. Be cautious interpreting complete absence, as Cathepsin B is widely expressed; reduced signal in knockdown samples is more realistic than complete loss.

Can I use this antibody for immunofluorescence to visualize lysosomal Cathepsin B?

Yes, this antibody is validated for Western blot; immunofluorescence validation is in progress. In fixed cells, expect punctate perinuclear staining consistent with lysosomal localization; co-staining with LAMP1 or LAMP2 provides excellent spatial confirmation. Use standard methanol or paraformaldehyde fixation followed by permeabilization with 0.1-0.5% Triton X-100. Start with a 1:100 to 1:200 dilution of primary antibody; lysosomal antigens are often abundant enough for robust signal at these dilutions. Under some stress conditions or in cancer cells, Cathepsin B relocalizes to the cytosol or secretory pathway, so diffuse staining does not necessarily indicate antibody failure but may reflect biological redistribution.

How should I store this Cathepsin B antibody and what is the shelf life?

Store the antibody at -20°C in the supplied glycerol-containing storage buffer; do not freeze in frost-free freezers, which cycle temperature. The 100 µg aliquot is stable for at least 12 months under these conditions based on our internal QC testing. For frequent use, prepare working aliquots (e.g., 10 µL volumes) to avoid repeated freeze-thaw, which can reduce titre and increase aggregation. If you must store diluted antibody, prepare it in PBS with 0.02% sodium azide and 1% BSA, keep at 4°C, and use within two weeks. Rabbit polyclonal antibodies are generally robust, but cysteine protease targets like Cathepsin B benefit from careful handling to preserve optimal performance across applications.

Western blot validation for RP-CathepsinB — 2 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

Cathepsin-B: Propeptide domain — WB validation
WB · Panel 1 Cathepsin-B: Propeptide domain
Cathepsin-B: Heavy chain — WB validation
WB · Panel 2 Cathepsin-B: Heavy chain

Custom validation studies available on request — contact us.

Also known as:

  • CTSB
  • Cathepsin B
  • Cathepsin B1
  • APP secretase
  • APPS
  • EC 3.4.22.1
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →